99-23126. Exchange of Letters Between the Food and Drug Administration and the Canadian Food Inspection Agency
[Federal Register Volume 64, Number 172 (Tuesday, September 7, 1999)]
[Notices]
[Pages 48656-48660]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-23126]
[[Page 48656]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[FDA 225-98-4002]
Exchange of Letters Between the Food and Drug Administration and
the Canadian Food Inspection Agency
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is providing notice of
an exchange of letters (EOL's) between FDA and the Canadian Food
Inspection Agency. The purpose of the EOL's is to enhance the exchange
of information in emergency situations.
DATES: The agreement became effective March 2, 1998.
FOR FURTHER INFORMATION CONTACT: Ellen F. Morrison, Office of
Regulatory Affairs (HFC-130), Food and Drug Administration, 5600
Fishers Lane, Rockville, MD 20857, 301-443-1240.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 20.108(c), which
states that all written agreements and memoranda of understanding
between FDA and others shall be published in the Federal Register, the
agency is publishing notice of this EOL.
Dated: August 27, 1999.
William K. Hubbard,
Senior Associate Commissioner for Policy, Planning and Legislation.
BILLING CODE 4160-01-F
[[Page 48657]]
[GRAPHIC] [TIFF OMITTED] TN07SE99.002
[[Page 48658]]
[GRAPHIC] [TIFF OMITTED] TN07SE99.003
[[Page 48659]]
[GRAPHIC] [TIFF OMITTED] TN07SE99.004
[[Page 48660]]
[GRAPHIC] [TIFF OMITTED] TN07SE99.005
[FR Doc. 99-23126 Filed 9-3-99; 8:45 am]
BILLING CODE 4160-01-C
Document Information
- Effective Date:
- 3/2/1998
- Published:
- 09/07/1999
- Department:
- Food and Drug Administration
- Entry Type:
- Notice
- Action:
- Notice.
- Document Number:
- 99-23126
- Dates:
- The agreement became effective March 2, 1998.
- Pages:
- 48656-48660 (5 pages)
- Docket Numbers:
- FDA 225-98-4002
- PDF File:
-
99-23126.pdf